Case Report
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Nov 15, 2022; 14(11): 2273-2287
Published online Nov 15, 2022. doi: 10.4251/wjgo.v14.i11.2273
Surgical management of monomorphic epitheliotropic intestinal T-cell lymphoma followed by chemotherapy and stem-cell transplant: A case report and review of the literature
Abdul Saad Bissessur, Ji-Chun Zhou, Ling Xu, Zhao-Qing Li, Si-Wei Ju, Yun-Lu Jia, Lin-Bo Wang
Abdul Saad Bissessur, Ji-Chun Zhou, Ling Xu, Zhao-Qing Li, Si-Wei Ju, Lin-Bo Wang, Department of Surgical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang Province, China
Yun-Lu Jia, Department of Medical Oncology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang Province, China
Author contributions: Bissessur AS and Zhou JC wrote this paper; Bissessur AS conducted literature review; Xu L, Li ZQ, Ju SW, and Jia YL contributed in data acquisition and manuscript preparation; Jia YL, Zhou JC, and Wang LB were responsible for patient care and data analysis; Zhou JC and Wang LB substantively reviewed the manuscript; all authors read and approved the final manuscript.
Informed consent statement: Informed written consent was obtained from the patients for the publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Lin-Bo Wang, Doctor, MBBS, MD, PhD, Attending Doctor, Chief Doctor, Director, Professor, Surgical Oncologist, Department of Surgical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, No. 3 Eastern Qingchun Road, Hangzhou 310006, Zhejiang Province, China. linbowang@zju.edu.cn
Received: July 26, 2022
Peer-review started: July 26, 2022
First decision: August 8, 2022
Revised: August 22, 2022
Accepted: October 11, 2022
Article in press: October 11, 2022
Published online: November 15, 2022
Core Tip

Core Tip: Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) is a rare and rapidly progressive intestinal T-cell non-Hodgkin lymphoma. Currently, there is no standardized treatment or diagnostic protocols for MEITL. Chemotherapy followed by stem-cell transplant postoperatively has shown promising results in terms of remission and progression free survival. Since MEITL is associated with a poor prognosis and high recurrence, it is crucial that the oncologist should follow and monitor any relapsing signs.